Skip to main contentSkip to navigation
Sirius Investors

CNNA Stock: Cann American Corp. Stock Price, Analysis & Insights

Get live CNNA stock price $0.00, comprehensive Cann American Corp. stock analysis, charts, news, and expert forecast. Real-time CNNA stock data and investment insights.

0.00
0.00%Today
CNNACann American Corp. • Other OTC • Healthcare
Market Cap
1.40M
Volume
7.00K
52W High
0.01
52W Low
0.00

Loading chart data...

Cann American Corp. (CNNA) Overview

Cann American Corp. (CNNA) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, CNNA trades at $0.00 with a market capitalization of 1.40M . Over the past 52 weeks, CNNA has traded between $0.00 and $0.01 , with the current price positioned at approximately 24% of this range . The st...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 1.40M
  • Current price: $0.00
  • 52-week range: $0.00 - $0.01
  • P/E ratio: 0.19

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 a...

Company Information

CEO
Jason R. Tucker
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1

Contact Information

Address
320 Santana Drive
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -0.67) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Cann American Corp. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Cann American Corp.
  • Investors should consider how Cann American Corp. fits within their overall portfolio allocation

Market Cap

1.40M

Beta

-0.67

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.